Expression of NFκB or p21 were elevated along with MET in a tumor specific manner, but lacked overall correlation (Figure 3B) suggesting that MET-MAPK could potentially be a relevant mechanism in cTCL. The gene discussed is NFKB1; the disease is primary cutaneous T-cell non-Hodgkin lymphoma.